Ligand Pharmaceuticals' GAAP net income for 2021 was $57.586 million, compared to a loss of $2.985 million in the previous year. Revenue increased 48.7% to $277.133 million from $186.419 million a year earlier.
Ligand Pharmaceuticals' GAAP net income for 2021 was $57.586 million, compared to a loss of $2.985 million in the previous year. Revenue increased 48.7% to $277.133 million from $186.419 million a year earlier. 
investor.ligand.com
English (US) 